Researchers compared the use of aflibercept 8 mg and 2 mg in patients with various retinal vein occlusion subtypes.
Frida Velcani
Frida Velcani is an MD-MBA student with the Geisel School of Medicine and Tuck School of Business at Dartmouth. She is dedicated to improving patient outcomes by expanding access to information about innovative treatments and aims to carry this commitment forward in her future career as an ophthalmologist.
